Home / Inspections / 1078188

FDA Inspection 1078188 — Aino Co., Ltd. of North China Pharma. Group

Aino Co., Ltd. of North China Pharma. Group — FEI 3004090057

The FDA completed an inspection of Aino Co., Ltd. of North China Pharma. Group on January 17, 2019 in Shijiazhuang, Hebei. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 17, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Shijiazhuang, Hebei (China)

Facility

Other inspections at this facility

  • 1267899 (NAI Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 972459 (VAI Fri Apr 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888168 (VAI Fri Jun 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 754952 (VAI Fri Nov 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 598515 (VAI Thu Jul 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources